Chlamydia Testing Activity Dataset (CTAD): specification and technical guidance
Guidance and specifications for the recording and extraction of CTAD data from laboratories in England processing LA and NHS commissioned chlamydia tests.
Latest change: First published.
AI Summary
The Chlamydia Surveillance System (CTAD) acts as the centralized data collection framework for all chlamydia testing performed within England, encompassing tests from both National Health Service (NHS) and local authority-commissioned laboratories. This guidance document serves as the primary dataset specification, outlining the technical requirements and reporting standards necessary for measuring national screening activity. Within the broader UK regulatory and public health framework, the guidance ensures that diagnostic providers, laboratories, and service commissioners maintain high standards of data accuracy and interoperability. Although this document is a technical guidance rather than a report of specific violations or inspection findings at a single company, it establishes the mandatory reporting structure for all participating diagnostic entities. Stakeholders are required to implement these dataset specifications into their laboratory information management systems to ensure consistent reporting. The primary objective is to provide a comprehensive view of screening volume and positivity rates, enabling health authorities to make informed decisions regarding sexual health services. Compliance with these specifications is essential for the integrity of the national surveillance program. All laboratories and service providers must verify that their data submission protocols align with the updated CTAD requirements to avoid reporting gaps and ensure that public health interventions are based on robust evidence-based data across the healthcare system.
The full document, source attachments, and change history are available on KeyPedia. Sign in to view.